However, if an underlying factor of tumorigenesis was increased activation of proliferative pathways by altered insulin signaling in ChREBP-KO mice [21], one would expect to see differences between tumor development in normoglycemic mice and those with streptozotocin-induced insulin deficiency. The gene discussed is MLXIPL; the disease is neoplasm.